45: Gray Zone Lymphoma
Gray Zone Lymphoma Caron A. Jacobson1 and Ann S. LaCasce2 1Dana-Farber Cancer Institute, Boston, MA, USA 2Dana-Farber/Partners CancerCare, Boston, MA, USA Case study 45.1 A 62-year-old woman presents to the…
Gray Zone Lymphoma Caron A. Jacobson1 and Ann S. LaCasce2 1Dana-Farber Cancer Institute, Boston, MA, USA 2Dana-Farber/Partners CancerCare, Boston, MA, USA Case study 45.1 A 62-year-old woman presents to the…
Primary Mediastinal Large B-Cell Lymphoma Pier Luigi Zinzani Institute of Hematology “Seràgnoli,” University of Bologna, Bologna, Italy Primary mediastinal large B-cell lymphoma (PMLBCL) is a subtype of diffuse large B-cell…
Burkitt Lymphoma Mark Roschewski and Wyndham Wilson National Cancer Institute, National Institutes of Health, Bethesda, MD, USA Case study 44.1 A 55-year-old man presents to the emergency department with the…
Relapsed and Refractory Acute Myeloid Leukemia Stefan H. Faderl Hackensack University Medical Center, Hackensack, NJ, USA Case study 12.1 A 54-year-old woman is diagnosed with acute myeloid leukemia (AML). The…
Marginal Zone Lymphoma Sarah Rutherford, Wayne Tam, and Peter Martin Weill Cornell Medical College, New York, NY, USA 1. How is marginal zone lymphoma (MZL) distinguished from other non-Hodgkin’s lymphomas (NHLs)?…
Prognostic Markers and Models in Acute Lymphoblastic Leukemia Dieter Hoelzer University Hospital, Frankfurt am Main, Germany Acute lymphoblastic leukemia (ALL) is not a uniform disease but is characterized by subgroups…
Diffuse Large B-Cell Lymphoma Andrew D. Zelenetz Memorial Sloan Kettering Cancer Center, and Weill-Cornell Medical Center, New York, NY, USA Introduction Diffuse large B-cell lymphoma (DLBCL) is the most common…
Eosinophilic Myeloproliferative Disorders Jason Gotlib Stanford University School of Medicine/Stanford Cancer Institute, Stanford, CA, USA Case study 27.1 A 54-year-old man with no significant medical history reports a 3-month history…
Follicular Lymphoma Myron S. Czuczman Roswell Park Cancer Institute, Buffalo, NY, USA Case study 39.1 A 75-year-old retired schoolteacher notes an increase in some nontender bilateral neck lymph nodes (LNs)…
Chronic Myeloid Leukemia: Chronic Phase Jerald P. Radich Fred Hutchinson Cancer Research Center, Seattle, WA, USA Introduction Tyrosine kinase inhibitors (TKIs) have irrevocably changed the care of chronic myeloid leukemia…